|
Colorado
Boulder
 The
sequencing of the human genome sets the stage for proteomics - the large-scale
analysis of proteins. By revealing the complex relationships between proteins
and both disease and health, proteomics will create unprecedented opportunities
in the research and clinical arenas. SomaLogic's arrays for proteomics
will be based on the company's proprietary photoaptamer technology and
will allow the simultaneous quantitative analysis of multiple proteins.
Initial applications will be offered to life sciences and clinical researchers
on a service basis and will focus on inflammation and angiogenesis. Through
time, SomaLogic will expand its arrays to other protein families of interest
and offer stand-alone proteomic analysis systems. SomaLogic's clinical
development efforts will use these same arrays as the basis for a new
generation of diagnostics. Through the discovery of the complex patterns
of protein expression associated with health and disease, SomaLogic will
help drive a new approach to clinical medicine.
Idaho
Montana
Wyoming
|
